Literature DB >> 18368613

A systematic review of cognitive and behavioural therapies for methamphetamine dependence.

Nicole K Lee1, Richard A Rawson.   

Abstract

INTRODUCTION AND AIMS: The use of methamphetamine is widespread and poses significant challenges for treatment providers. Much of the treatment knowledge about this group has been extrapolated from studies of treatment for cocaine dependence. Medications have been shown to be of limited effectiveness for methamphetamine users, making psychological interventions the treatment of choice. APPROACH: This paper describes a systematic review of cognitive-behavioural and behavioural interventions for methamphetamine users. A systematic search of published literature was undertaken focusing only on randomised trials. KEY
FINDINGS: There were a relatively small number of intervention studies that compared cognitive-behavioural or behavioural interventions using randomised trial methodology. Most commonly, studies examined cognitive-behaviour therapy (CBT) and/or contingency management (CM). Treatment with CBT appears to be associated with reductions in methamphetamine use and other positive changes, even over very short periods of treatment (two and four sessions). CM studies found a significant reduction of methamphetamine during application of the procedure, but it is not clear if these gains are sustained at post-treatment follow-up. IMPLICATIONS: The review highlights that there are effective treatments for methamphetamine dependence. Alcohol and other drug (AOD) clinicians are familiar with these types of interventions and should use them and convey to clients that they are effective. Services and policy makers should ensure that best practice interventions are implemented within AOD services.
CONCLUSION: Psychological intervention is effective in addressing methamphetamine use and dependence. CBT and contingency management are two accessible interventions that are implemented easily within current AOD services. There is still more work to conduct in improving methamphetamine treatment, however, and further research into cognitive-behavioural and behavioural treatments for methamphetamine users is required, with a focus on improving longevity of the effect of intervention and improving effectiveness among more complex presentations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18368613      PMCID: PMC4445690          DOI: 10.1080/09595230801919494

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  19 in total

1.  Contingency management: schedule effects.

Authors:  John M Roll; Steve Shoptaw
Journal:  Psychiatry Res       Date:  2006-08-14       Impact factor: 3.222

Review 2.  Psychosocial approaches to psychostimulant dependence: a systematic review.

Authors:  James Shearer
Journal:  J Subst Abuse Treat       Date:  2006-10-20

3.  Contingency management for the treatment of methamphetamine use disorders.

Authors:  John M Roll; Nancy M Petry; Maxine L Stitzer; Mary L Brecht; Jessica M Peirce; Michael J McCann; Jack Blaine; Marilyn MacDonald; Joan DiMaria; Leroy Lucero; Scott Kellogg
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

4.  Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence.

Authors:  Steven Shoptaw; Alice Huber; James Peck; Xiaowei Yang; Juanmei Liu; John Roll; Benjamin Shapiro; Erin Rotheram-Fuller; Walter Ling
Journal:  Drug Alcohol Depend       Date:  2006-04-18       Impact factor: 4.492

5.  Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.

Authors:  Steven Shoptaw; Cathy J Reback; James A Peck; Xiaowei Yang; Erin Rotheram-Fuller; Sherry Larkins; Rosemary C Veniegas; Thomas E Freese; Christopher Hucks-Ortiz
Journal:  Drug Alcohol Depend       Date:  2004-11-28       Impact factor: 4.492

6.  Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction.

Authors:  Amanda Baker; Nicole K Lee; Melissa Claire; Terry J Lewin; Tanya Grant; Sonja Pohlman; John B Saunders; Frances Kay-Lambkin; Paul Constable; Linda Jenner; Vaughan J Carr
Journal:  Addiction       Date:  2005-03       Impact factor: 6.526

Review 7.  Behavioral therapies for drug abuse.

Authors:  Kathleen M Carroll; Lisa S Onken
Journal:  Am J Psychiatry       Date:  2005-08       Impact factor: 18.112

8.  Effects of brief cognitive-behavioral interventions on confidence to resist the urges to use heroin and methamphetamine in relapse-related situations.

Authors:  Cheng-Fang Yen; Hsiao-Yen Wu; Ju-Yu Yen; Chih-Hung Ko
Journal:  J Nerv Ment Dis       Date:  2004-11       Impact factor: 2.254

9.  Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program.

Authors:  Adi Jaffe; Steven Shoptaw; Judith Stein; Cathy J Reback; Erin Rotheram-Fuller
Journal:  Exp Clin Psychopharmacol       Date:  2007-06       Impact factor: 3.157

Review 10.  Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders.

Authors:  W P Knapp; B G O Soares; M Farrel; M S Lima
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18
View more
  87 in total

1.  Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.

Authors:  Craig R Rush; William W Stoops; Joshua A Lile; Paul E A Glaser; Lon R Hays
Journal:  Psychopharmacology (Berl)       Date:  2010-11-12       Impact factor: 4.530

2.  Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals.

Authors:  Dara G Ghahremani; Golnaz Tabibnia; John Monterosso; Gerhard Hellemann; Russell A Poldrack; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

3.  Pretreatment drug use characteristics and experiences among patients in a voluntary substance abuse treatment center in Malaysia: A mixed-methods approach.

Authors:  Archana Krishnan; Shan-Estelle Brown; Mansur A Ghani; Farrah Khan; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Subst Abus       Date:  2016-02-25       Impact factor: 3.716

4.  Applying behavioral activation to sustain and enhance the effects of contingency management for reducing stimulant use among individuals with HIV infection.

Authors:  Matthew J Mimiaga; Elizabeth F Closson; David W Pantalone; Steven A Safren; Jennifer A Mitty
Journal:  Psychol Health Med       Date:  2018-09-13       Impact factor: 2.423

5.  Applying lessons from task sharing in global mental health to the opioid crisis.

Authors:  Jessica F Magidson; Helen E Jack; Kristen S Regenauer; Bronwyn Myers
Journal:  J Consult Clin Psychol       Date:  2019-10

6.  mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats.

Authors:  Justin T Gass; Megan P H Osborne; Noreen L Watson; Jordan L Brown; M Foster Olive
Journal:  Neuropsychopharmacology       Date:  2008-09-17       Impact factor: 7.853

Review 7.  A review of treatment options for co-occurring methamphetamine use disorders and depression.

Authors:  Tracy L Hellem; Kelly J Lundberg; Perry F Renshaw
Journal:  J Addict Nurs       Date:  2015 Jan-Mar       Impact factor: 1.476

8.  The Feasibility of Interventions to Reduce HIV Risk and Drug Use among Heterosexual Methamphetamine Users.

Authors:  Karen F Corsi; Wayne E Lehman; Sung-Joon Min; Shannon P Lance; Nicole Speer; Robert E Booth; Steve Shoptaw
Journal:  J AIDS Clin Res       Date:  2012-06-04

9.  Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables.

Authors:  Andy C Dean; Edythe D London; Catherine A Sugar; Christina M R Kitchen; Aimee-Noelle Swanson; Keith G Heinzerling; Ari D Kalechstein; Steven Shoptaw
Journal:  Drug Alcohol Depend       Date:  2009-07-15       Impact factor: 4.492

Review 10.  Pharmacotherapy of amphetamine-type stimulant dependence: an update.

Authors:  Matthew Brensilver; Keith G Heinzerling; Steven Shoptaw
Journal:  Drug Alcohol Rev       Date:  2013-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.